| Serial Number | 90867247 |
| Word Mark | ADAPT |
| Filing Date | Thursday, August 5, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, May 9, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical products, preparations, and substances for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; biological products, preparations, and substances in the nature of medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; immunotherapies being medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; vaccines; pharmaceuticals in the nature of biotechnology platform technology, namely, viral and vaccine vectors for delivery and insertion of function-altering genetic material into human and animal patients, plants, and crops, for visualization of specific cell types, for inducing humoral and cell-mediated responses, for targeting and killing cancer cells, for removing pathological functions, for controlling biological pests, and for boosting crop yields |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 30, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EpicentRx, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Event Date | Event Description |
| Tuesday, May 9, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, May 9, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, May 9, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, October 25, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, October 25, 2022 | FINAL REFUSAL E-MAILED |
| Tuesday, October 25, 2022 | FINAL REFUSAL WRITTEN |
| Friday, September 23, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 22, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 22, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 22, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 22, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 22, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 16, 2022 | ASSIGNED TO EXAMINER |
| Thursday, September 30, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 9, 2021 | NEW APPLICATION ENTERED |